Delivery of coated hydrophobic active agent particles

Patent metadata

Field	Value
Publication number	US-9757497-B2
Application number	US-201213469844-A
Country	US
Kind code	B2
Filing date	May 11, 2012
Priority date	May 20, 2011
Publication date	Sep 12, 2017
Grant date	Sep 12, 2017

Abstract

Embodiments of the invention include devices and coatings for devices including coated hydrophobic active agent particles. In an embodiment, the invention includes a drug delivery device including a substrate; and coated therapeutic agent particles disposed on the substrate, the coated therapeutic agent particles comprising a particulate hydrophobic therapeutic agent; and a cationic agent in contact with the particulate hydrophobic therapeutic agent. Other embodiments are also included herein.

First claim

The invention claimed is:

1. A drug delivery coating comprising
a polymeric layer, the polymeric layer comprising a hydrophilic outer surface;
coated therapeutic agent particles disposed over the hydrophilic outer surface, the coated therapeutic agent particles comprising
a particulate hydrophobic therapeutic agent core;
and a cationic agent selected from the group consisting of polyethyleneimine (PEI), 1,2-dioleoyl-3-trimethylammonium-propone (DOTAP) and polyamidoamine dendrimers (PAMAM) in contact with the particulate hydrophobic therapeutic agent core;
further comprising the cationic agent disposed between the coated therapeutic agent particles;
wherein the coated therapeutic agent particles and cationic agent directly contact an in vivo environment when the drug delivery coating is disposed within a vessel of a subject.

2. The drug delivery coating of claim 1 , further comprising an additive disposed between the coated therapeutic agent particles, the additive selected from the group consisting of saccharides and amphiphilic compounds.

3. The drug delivery coating of claim 2 , the additive selected from the group consisting of glycogen, dextran, and F68 poloxamer.

4. The drug delivery coating of claim 1 , further comprising an additive disposed between the coated therapeutic agent particles, the additive selected from the group consisting of polyethylene glycol and derivative thereof, polyvinyl pyrrolidone and derivatives thereof, polyvinyl alcohol and derivatives thereof, and poloxamers.

5. The drug delivery coating of claim 1 , wherein the particulate hydrophobic therapeutic agent is in a crystalline form.

6. The drug delivery coating of claim 1 , the particulate hydrophobic therapeutic agent selected from the group consisting of paclitaxel and sirolimus.

7. The drug delivery coating of claim 1 , the polymeric layer comprising polyvinylpyrrolidone.

Assignees

• Slager Joram
• Surmodics Inc

Inventors

• Slager Joram

Classifications

• A61L2300/602

  Type of release, e.g. controlled, sustained, slow · CPC title

• F04C2270/0421

  Controlled or regulated · CPC title

• A61L29/085

  Macromolecular materials · CPC title

• A61L2300/802

  Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants · CPC title

• A61K9/70

  Web, sheet or filament bases {; Films; Fibres of the matrix type containing drug (hollow drug-filled fibres A61K9/0092)} · CPC title